Could cause temporary or reversible harm; serious harm is unlikely.
Presence of foreign substance: plastic-like substance.
| Brand name | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
| Generic name | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
| Active ingredient(s) | HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM |
| Distributed by / for | Macleods Pharma USA, Inc. Princeton, NJ 08540 |
| NDC | 33342-050-44 |
| Full product label | Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44 |
| Recalling firm | MACLEODS PHARMA USA, INC |
| Distribution | USA Nationwide |
| Quantity | 1,048 bottles |
| Recall initiated | 2024-05-07 |
| Report date | 2024-05-22 |
| Recall completed | — |
| Recall number | D-0498-2024 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗